This clinical trial of pembrolizumab in combination with metronomic cyclophosphamide assesses the efficacy and safety of PD-1 targeting in combination with metronomic chemotherapy in sarcomas.
http://ift.tt/2sl5Lj1
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου